OTC: WRHLF | AQSE: LIFE
The CBD market is, by any reasonable measure, on an explosively upward trajectory.
The next CBD Wellness Stock Poised to Explode Skyward!
World High Life (AQSE: LIFE | OTC: WRHLF) is positioned to capitalize on Europe’s fast-growing CBD market and plans to grow into an international leader in the legal CBD Wellness and medicinal cannabis space!
CBD Wellness and Medical cannabis investment company World High Life has purchased Great Britain's Love Hemp in the UK’s #1 CBD supplier. World High Life is set to expand Love Hemp's already significant business throughout the UK and more extensively into Europe.
The European CBD Wellness and Medicinal Cannabis Industry is being called the Next Emerging Market to Experience the “GREEN RUSH”
The CBD Wellness & Medicinal Cannabis Industry in the UK is where Canada was 5 years ago and is providing a new frontier investment opportunity!
“We’re always looking for new markets and the UK is poised for growth.” David Stadynk CEO
Stadnyk is one of the first movers from the legal Canadian Cannabis Sector and set up World High Life with the aim of finding opportunities in Europe’s legal CBD Wellness and Medicinal cCannabis space.
Market research commissioned by the Centre for Medicinal Cannabis (CMC) estimates that the CBD market is currently one of the fastest growing wellbeing product categories in the UK.
- The CMC research estimates that 1.3 million consumers are spending over £300M per year on CBD products. In comparison, the CBD market is larger than the total UK Vitamin D (£145M) and Vitamin C market (£119M) combined.
- Support for legalization of cannabis among CBD users (75%) is higher than that of the total population (47%)
- Centre for Medicinal Cannabis indicates the market is forecasted to grow in double digits each year and will hit £1B per year by 2025.
Europe: The Big Oppportunity
It is estimated that Europe is home to a population of 742 million and an annual combined GDP of over €15 trillion.
This combination of a large combined population as well as the combination of the globally significant economies provides an incredibly large market where annual governmental health care expenditure alone is over €1,08 trillion and total annual healthcare spend is estimated at €2.3 trillion.
Over the next five years, the global CBD market is expected to accelerate to $23.6bn, according to Grand View Research and Europe’s CBD market alone is set to grow by 400%.
Europe is seen as a potential hotbed for new market development as at least six European countries currently preparing new legislative bills on Medicinal Cannabis for local parliaments and most countries in the EU currently allow some form of Medicinal Cannabis.
Cannabis Trades Association UK has reported that the number of people using CBD oil has quadrupled in past two years.
Prohibition Partners reports that the European Medicinal Cannabis market could be valued at almost €55 billion once all markets have implemented legislation and market infrastructure!
In respect of the European CBD Market, Brightfield Group have estimated significant growth over the next four years, estimating the market at $318 million in 2018 and expecting that it will grow over 400 percent through 2023!
Brightfield Group expects the European CBD market to be worth $1.7 billion by 2023!
Love Hemp Ltd is a wholly owned subsidiary of World High Life (AQSE: LIFE | OTC: WRHLF)
The company is targeting international growth with the aim to become a world CBD Wellness leader in 4 phases, immediate UK & Europe, Short term USA, Medium term Canada, with a continuing push into niche markets in Asia and beyond!
Love Hemp is the UK's #1 CBD and Hemp product supplier!
- An extensive CBD product range, now approaching 100 SKU’s.
- Over 40 product lines comprising of oils, sprays, and vapes and a variety of edible and water-based CBD products.
- All products are certified THC free; third party tested under strict laboratory conditions and have a guaranteed CBD concentration.
- Distribution and retail relationships have been established with over 1,900 stores in the UK and Europe, including leading brands Boots, Ocado, Holland & Barrett and WH Smith!
Love Hemp is proud to operate in a regulated way in an unregulated market.
New product development is at their heart and Love Hemp was the first functional spring water in the UK to be infused with CBD. Oils, sprays, vapes, chocolate, jelly domes and beauty products including the first CBD infused face mask and body salves have all followed.
The Company has a THREE-prong strategic model, delivering diversification and growth on multiple fronts:
- The Love Hemp branded product line at retail locations and online
- CBDOilsUK.com - a robust online sales channel direct to consumer (www.cbdoilsuk.com)
- Botanicals - which produces white label CBD products for over 3 dozen brands in the UK and Europe (www.LHBotanicals.com)
ON-TREND WELLBEING BRAND
Love Hemp has secured a number of notable listings with leading retailers and was flagged as an on-trend wellbeing brand to watch by national media including The Times, Daily Telegraph, Sunday Times and The Independent.
UFC World Champion, Georges St-Pierre is the Love Hemp, World High Life Brand Ambassador – delivering a vast promotional platform with one of the most recognized sport and health personalities on the planet!
Love Hemp Immune products support wellness and immune system.
Natural defenses are crucial, especially during times like we are experiencing now.
When the world changed the company also changed its plans and worked around the clock to bring Love Hemp Immune early!
CBD is short for cannabidiol and is one of 113 cannabinoids in the cannabis plant. It is the second most prevalent of the active ingredients of cannabis.
Derived from the hemp plant, CBD is legal in the UK CBD oil is legal in the UK if it has a THC content of below 0.02%.
THC – or tetrahydrocannabinol – is derived from THC rich cannabis and is a psychoactive substance. As such, it is not legal to buy in the UK.
POTENTIAL MEDICAL BENEFITS OF CBD
CBD is thought to influence opioid receptors that regulate pain and glycine receptors involved in the regulation of the "feel-good" hormone serotonin.
WHO IS WORLD HIGH LIFE
AQSE: LIFE | OTC:WRHLF
World High Life was launched by first movers from the legal Canadian Cannabis Sector; the founders of Supreme Cannabis and 1933 Industries, delivering vast experience and expertise to identify, invest in and rapidly grow businesses in the legalized CBD Wellness and legal Medicinal Cannabis industry!
The Directors believe that there are numerous investment opportunities within both private and public companies as they relate to Medicinal Cannabis, CBD and Hemp and may make investments in early-stage businesses and/or more mature operating companies. The company is likely to be an active investor and acquire control in certain situations, although it may also consider acquiring non-controlling positions.
Love Hemp Acquisition
World High Life is positioned to secure "best in class" future acquisitions, which can benefit greatly through the expertise and capital needed to generate exponential growth.
The Company will undertake due diligence on investment opportunities encompassing the breadth of the Medicinal Cannabis, Hemp and CBD Wellness Sectors including their ancillary industries and services including, but not limited to:
- The manufacture and distribution of Medicinal Cannabis, Hemp and CBD wellness products;
- Pharmacology commercial is at ion commercialization of Medicinal Cannabis, Hemp and CBD;
- Professional prescription by practitioners and after care as it relates to Medicinal Cannabis;
- Statistical management, laboratory testing and compliance in respect of Medicinal Cannabis, Hemp and CBD wellness sectors
- The development of CBD within the wellness sector including retail products such as patches, topical ointments, tinctures, beverages, powdered supplements as well as vaping capsules, e-liquids and oils.
WORLD HIGH LIFE TEAM
Robert is a Chartered Professional Accountant with 12 years’ experience in finance, reporting, regulatory requirements, public company administration, equity markets, and financing of publicly traded companies. He commenced his career in private practice and since 2014 he has served as a consultant for a number of TSX Venture Exchange and Canadian Securities Exchange (CSE) listed companies. Robert has extensive experience in the cannabis, manufacturing, natural resource, and retail industries. He received a BBA from Simon Fraser University and is a member in good standing of the Chartered Professional Accountants of British Columbia.
Andrew has over 25 years’ experience in sourcing, developing and financing companies across Canada, the US and UK. Andrew is a seasoned Director, holding senior positions at international public and private investment and operational companies. He also works closely with several Family Offices that seek access to an array of transformational opportunities and is a former Founder and CEO of a TSX Venture Exchange Top 50 Company.
Kevin has over 30 years’ experience in the investment banking industry having started his career in wealth management with Merrill Lynch and then UBS before spending nine years at the New York Stock Exchange with responsibility for over 150 listings of North American and Asia-Pacific companies. Kevin is currently a partner in a Toronto based private equity group that specializes in strategic advisory and investments into private technology and healthcare companies. Kevin holds both an Economics degree and an MBA from Rutgers University as well as NASD securities licenses.
Charlie has over 10 years of experience working as a Canadian corporate and securities lawyer at a large international law firm in New York. With extensive cross-border corporate and securities law experience, Charlie has worked on numerous corporate transactions, including mergers and acquisitions, public and private offerings of securities for investment funds, private equity funds and other alternative investment vehicles in the Canadian markets. He also has significant experience advising broker dealers, advisers and investment fund managers on Canadian compliance issues. Charlie graduated from University of Victoria, British Columbia and is a member of the Law Society of Upper Canada, The Canadian Bar Association and the American Bar Association. He has resided in New York since 2009.
Geographically, World High Life believe that significant opportunities exist:
- Europe, to capitalize on the existing Medicinal Cannabis, CBD and Hemp industries, the ancillary services such as advisory firms and the large market potential as result of the trend towards deregulation as it relates to Medicinal Cannabis, with no less than 13 countries having allowed or are currently discussing the use of Cannabis for medical reasons;
- Canada, where the estimated total market size of Medicinal Cannabis is expected to reach CAD$2.35 billion dollars by 2025 (up from CAD$600 million in 2017);
- Africa and South America, where low cost production of Medicinal Cannabis and Hemp can be achieved in conjunction with the building and operating plants to create derivative products for the wellness and medical markets;
- Israel, where a number of products are being developed including edible, dissolvable and topical cannabinoids in order to improve the way Medicinal Cannabis and CBD products are administered to improve effectiveness;
- Asia, where the large population and continued modernization of infrastructure drives low-cost production and process, as well as medical and biotechnological innovation.
The bottom line
- World High Life has acquired Love Hemp, the UK’s #1 CBD supplier. Love Hemp is targeting international growth with the aim to become a world CBD wellness leader!
- The company has a huge European market. Brightfield Group expects CBD market on the continent to be worth $1.7 billion by 2023!
- Global cannabidiol market size is expected to reach $23.6 billion, expanding at a CAGR of 22.2%, according to Grand View Research.
- Company is targeting Europe, Canada, Africa, South America, Israel, and Asia.
- The demand for cannabidiol (CBD) for medical and wellness purposes is fast-growing due to its applications for health and well being including immunity and defense from viruses.
- The company only recently began trading on the OTCQB under the symbol WRHLF and is flying under the radar right now.
- Trading on the AQSE Growth Market in the UK and on the OTCQB in North America, the Company is currently making exploring applications for secondary additional listings in Europe and CanadaVienna, Frankfurt, and Canadian Markets, providing investors around the world with opportunities to participate!
Add World High Life (AQSE: LIFE | OTC: WRHLF to your watchlist right away, 2020 Could Be the Year the Company Catapults into the Spotlight!
Start your research on WRHLF right away and as always, trade safe.
Sincerely,
Adam Cohen
Sources:
https://finance.yahoo.com/quote/wrhlf?ltr=1
https://www.otcmarkets.com/stock/WRHLF/
https://www.worldhighlife.uk/
https://www.verywellhealth.com/cbd-oil-benefits-uses-side-effects-4174562
Continue Reading...
Disclaimer
We have received a total sum of one hundred thousand dollars via a bank wire for the awareness of WRHLF which has since expired.
Any type of reproduction, copying or distribution of the material in this email is prohibited without a written consent from the site owner.
Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be c.ompensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice.
We are not held liable or responsible for the information in press releases issued by the companies discussed in these email’s. Please do your own due diligence.